Delivery Order SPE2DB25D3005-SPE2DB25FQDNW

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The contract has a ceiling value of $3,268.66 and is a firm fixed price delivery order with a completion date of November 27, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,483.36, is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The award has an ultimate completion date of December 4, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,003.00, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of February 25, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,051.05, is for the purchase of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has a period of performance through February 20, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen also holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,229.80, is a Firm Fixed Price Delivery Order for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen is the prime contractor, and the contract was not set aside for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,006.00 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a ceiling value of $6,006.00 and a performance period ending on March 5, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,503.01 firm fixed-price contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,208.87 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has a ceiling value of $8,168.76 and a completion date of September 22, 2023. The contract is a delivery order, with a firm fixed price pricing type. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a diabetes management medication, with an ultimate completion date of November 18, 2024 and a ceiling value of $41,744.94. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQDNW
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The award has a ceiling value of $3,003.00 and is a firm fixed-price delivery order contract, with a period of performance through March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/21/25, 9:57 AM